AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 3.78Bです。
高配当
同社は高配当銘柄であり、最新の配当性向は30.45%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は30.45%です。
割安
同社の最新のPBは3.07で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は57.02M株で、前四半期比で13.66%減少しています。
ETHSXが保有
スター投資家ETHSXは本銘柄を3.55M株保有しています。